Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
0.8127
-0.0173 (-2.08%)
At close: Oct 9, 2026, 4:00 PM EDT
0.8289
+0.0162 (1.99%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $10.39 million as of October 9, 2026. It is the 41,454th most valuable company in the world and the 5,627th biggest in the United States. Its market cap has decreased by 79.04% in one year.
Market Cap
10.39M
Enterprise Value
3.07M
1-Year Change
-79.04%
Global Rank
Country Rank
#5,627 United States
Category
ChartMarket Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $30.33M to $10.39M, a decrease of -65.74%. That is a compound annual growth rate of -15.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 10.39M | -69.34% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cerenome | 12.41M |
| Intensity Therapeutics | 12.41M |
| Passage Bio | 12.40M |
| Daré Bioscience | 12.08M |
| CytoMed Therapeutics | 11.70M |
| BioLineRx | 11.68M |
| Phio Pharmaceuticals | 11.61M |
| GT Biopharma | 11.19M |